DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair, With death on the horizon, nothing will not stop me except God................DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 25Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK GENERICS at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contribution

Saturday 17 January 2015

(1 S, 2S)-2-(4-Bromo-phenyl)-cyclopropanecarboxylic acid

(1 S, 2S)-2-(4-Bromo-phenyl)-cyclopropanecarboxylic acid
Figure imgf000051_0001
To a stirred solution of (trans)-2-(4-bromophenyl)cyclopropanecarboxylic acid (6.52 g, 27.04 mmol), which can be prepared in accordance with the process set forth on page 82 of WO 2009/024823, in 400 ml of EtOH was added a solution of (R)-(+)-1 -(1 -Naphthyl)ethylamine (4.63g, 4.37 ml_, 27.04 mmol), in 1 00 ml of EtOH followed by 25 ml of H20. This was stirred at rt for about 4 h. The solid was collected by filtration and washed with 40 ml of cold EtOH/H20 (20/1 ) providing 3.18 grams of salt as a white solid (58 % recovery) equivalent to 1 .86 g of free acid. This was taken up in 2 N NaOH and extracted 5Xs with EtOAc. The aq. phase was placed on a rotary evaporator to remove the remaining EtOAc. The resulting clear solution was transferred to an erlenmeyer flask, cooled in an ice bath, and cone. HCI was added dropwise while stirring to pH 4. The resulting solid was collected by filtration providing 1 .63 g of Intermediate R. The product was analyzed by chiral SFC (UV detection) using isocratic method (mobile phase: 25% MeOH with 0.1 % DMEA, supercritical C02) on ChiralPak AD-H, 10 x 250 mm, 5 μιη particle size, giving an enantiomeric purity of >95%, Rt 3.88 min (isomer 1 ) and 4.79 min (isomer 2). 

1 H NM R (400 MHz, CDCI3) δ ppm 1 .37 (ddd, J=8.20, 6.64, 4.69 Hz, 1 H), 1 .67 (ddd, J=9.28, 5.08, 4.79 Hz, 1 H), 1 .87 (ddd, J=8.50, 4.69, 4.39 Hz, 1 H), 2.48-2.63 (m, 1 H), 6.87-7.06 (m, 2H), 7.37-7.46 (m, 2H).

http://www.google.com/patents/EP2536701A1?cl=en











DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO .....FOR BLOG HOME CLICK HERE

Join me on Linkedin

View Anthony Melvin Crasto Ph.D's profile on LinkedIn

Join me on Facebook FACEBOOK
Join me on twitterFollow amcrasto on Twitter     
Join me on google plus Googleplus

 amcrasto@gmail.com


No comments:

Post a Comment